Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wyeth’s Successful R&D Renovation: Neuroscience Shows Early Returns

Executive Summary

Six months after unveiling its "Project Springboard" efficiency initiative, Wyeth is holding up its neurosciences portfolio as an example of the success of the work-in-progress transformation of the company's R&D business

You may also be interested in...



Pipeline Dreams: GSK’s Witty Outlines Plans To Lower Phase III Attrition

As Andrew Witty takes the helm at GlaxoSmithKline, he has set his sights on tackling one of the industry's biggest challenges: reducing attrition in the late-stage pipeline

Pipeline Dreams: GSK’s Witty Outlines Plans To Lower Phase III Attrition

As Andrew Witty takes the helm at GlaxoSmithKline, he has set his sights on tackling one of the industry's biggest challenges: reducing attrition in the late-stage pipeline

Poussot Tapped As Wyeth CEO – Inherits Full Pipeline, Takeover Concerns

With the appointment of 20-year veteran Bernard Poussot as CEO, Wyeth is following a traditional approach to chief exec succession -avoiding drama by selecting a well-groomed insider with the standard pedigree from the business and marketing sides of the operation

Related Content

UsernamePublicRestriction

Register

LL1131980

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel